Answers are grounded in this paper and cite their sources.
The optimal management of euvolemic and hypervolemic hyponatremia remains controversial. The effectiveness of the vasopressin receptor antagonist tolvaptan on serum sodium normalization has been well described in the literature, although the associated risk of serum sodium overcorrection limits its use. Urea has been proposed as an alternative treatment option due to its milder serum sodium raising effects and adverse event profile.
No takes yet. Share an insight, caveat, or question.
Scalla et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: